Logistics of process R&D: Transforming laboratory methods to manufacturing scale

被引:32
作者
Federsel, HJ [1 ]
机构
[1] Proc R&D, AstraZeneca, SE-15185 Sodertalje, Sweden
关键词
D O I
10.1038/nrd1154
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In the past, process R&D - which is responsible for producing candidate drugs in the required quantity and of the requisite quality - has had a low profile, and many people outside the field remain unaware of the challenges involved. However, in recent years, the increasing pressure to achieve shorter times to market, the demand for considerable quantities of candidate drugs early in development, and the higher structural complexity - and therefore greater cost - of the target compounds, have increased awareness of the importance of process R&D. Here, I discuss the role of process R&D, using a range of real-life examples, with the aim of facilitating integration with other parts of the drug discovery pipeline.
引用
收藏
页码:654 / 664
页数:11
相关论文
共 32 条
  • [1] Anderson N. G., 2000, PRACTICAL PROCESS RE
  • [2] [Anonymous], BENCH MARKET EVOLUTI
  • [3] [Anonymous], 1999, PROCESS CHEM PHARM I
  • [4] [Anonymous], PRINCIPLES PROCESS R
  • [5] Enantioselective catalysis in fine chemicals production
    Blaser, HU
    [J]. CHEMICAL COMMUNICATIONS, 2003, (03) : 293 - 296
  • [6] Enantioselective catalysis in fine chemicals production
    Blaser, HU
    Spindler, F
    Studer, A
    [J]. APPLIED CATALYSIS A-GENERAL, 2001, 221 (1-2) : 119 - 143
  • [7] Carlsson E, 2002, CHEM BRIT, V38, P42
  • [8] COLLINS AN, 1992, CHIRALITY IND, V1
  • [9] COLLINS AN, 1997, CHIRALITY IND, V2
  • [10] Metrics to 'green' chemistry - which are the best?
    Constable, DJC
    Curzons, AD
    Cunningham, VL
    [J]. GREEN CHEMISTRY, 2002, 4 (06) : 521 - 527